You are here:
17 December 2018 / news

New partner at Loyens & Loeff Belgium

Loyens & Loeff is proud to announce that Robrecht Coppens will be appointed as partner within the Corporate/M&A department as of 1 January 2019.

Robrecht Coppens

Robrecht Coppens appointed as new partner

Robrecht Coppens (1984), lawyer, is a member of the Corporate/M&A practice group in Belgium. He focuses on mergers, acquisitions and joint ventures. Robrecht has developed extensive expertise in private equity transactions and is recognised in this sector as a next generation lawyer by The Legal 500 EMEA (2018). Clients appreciate his professional savvy combined with a pragmatic, no-nonsense approach and his commercial attitude. As Robrecht is passionate about entrepreneurship and innovation, and as he heads the Loyens & Loeff Startup Team, he is also involved in venture capital transactions and provides support to start-ups.

Marc Vermylen, Managing Partner Loyens & Loeff Belgium: “Robrecht's appointment is a real asset for the Corporate/M&A team and for the entire Brussels office. Through his expertise and innovative spirit, his appointment is in line with the vision of the future in which we want to develop our services. In a constantly evolving digital world, we welcome him to our group of partners, in which he and the others will play a leading role in making our firm the lawfirm of the future.”



New address for Loyens & Loeff Belgium

New address for Loyens & Loeff Belgium

We are pleased to announce that Loyens & Loeff Belgium has a new address as from 17 June 2019. read more
A legal framework for pop-up stores in the Brussels-Capital Region

A legal framework for pop-up stores in the Brussels-Capital Region

Since 19 May 2019, the Brussels Capital Region has a legal basis for short-term commercial leases. read more
First Belgian GDPR fine

First Belgian GDPR fine

On 28 May 2019, the Belgian Data Protection Authority imposed its first GDPR fine for misusing personal data for electoral campaign purposes. read more
Stay informed

Don't miss out. Stay up to date about our latest news and events.

Subscribe